Literature DB >> 11487266

Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy.

E Holmberg1, L E Holm, M Lundell, A Mattsson, A Wallgren, P Karlsson.   

Abstract

Exposure to ionizing radiation is a known risk factor for breast cancer and the fertility pattern is a recognized modifier of breast cancer risk. The aim of this study was to elucidate the interaction between these 2 factors. This study is based on a Swedish cohort of 17 202 women who had been irradiated for skin haemangiomas in infancy between 1920 and 1965. The mean age at treatment was 6 months and the median breast dose was 0.05 Gy (range 0-35.8 Gy). Follow-up information on vital status, parity, age at first childbirth and breast cancer incidence was retrieved through record linkage with national population registers for the period 1958-1995. Analyses of excess relative risk (ERR) models were performed using Poisson regression methods. In this cohort, the fertility pattern differed from that in the Swedish population, with significantly fewer childbirths overall and before 25 years of age but more childbirth after that age. There were 307 breast cancers in the cohort and the standardized incidence ratio (SIR) was 1.22 (95% CI 1.09-1.36). A linear dose-response model with stratification for fertility pattern and menopausal status resulted in the best fit of the data. ERR/Gy was 0.33 (95% CI 0.17-0.53). In absolute terms this means an excess of 2.1 and 5.4 cases per Gy per 10(4) breast-years in the age groups 40-49 and 50-59 years respectively. The fertility pattern influenced the breast cancer risk in this irradiated population in a similar way to that observed in other studies. SIR at dose = 0 was highest, 2.31, among postmenopausal nulliparous women (95% CI 1.48-3.40, n = 62). SIR at dose = 0 was lowest in pre- or postmenopausal women with a first childbirth before 25 years of age; 0.89 (0.71-1.09) and 0.88 (0.58-1.25) respectively. Thus, in addition to the dose-effect response in the cohort, part of the breast cancer excess could be explained by a different fertility pattern. The estimates of ERR/Gy for the various categories of age at first childbirth, number of children, menopausal status and ovarian dose were very similar, contradicting any interaction effects on the scale of relative risk. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2001        PMID: 11487266      PMCID: PMC2364061          DOI: 10.1054/bjoc.2001.1868

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

Review 1.  Follow-up studies of breast cancer incidence among atomic bomb survivors.

Authors:  M Tokunaga; C E Land; S Tokuoka
Journal:  J Radiat Res       Date:  1991-03       Impact factor: 2.724

2.  Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis.

Authors:  Z Hrubec; J D Boice; R R Monson; M Rosenstein
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

3.  A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose.

Authors:  C E Land; N Hayakawa; S G Machado; Y Yamada; M C Pike; S Akiba; M Tokunaga
Journal:  Cancer Causes Control       Date:  1994-03       Impact factor: 2.506

4.  Increased risk of breast cancer after low-dose irradiation.

Authors:  B Modan; A Chetrit; E Alfandary; L Katz
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

5.  Age at first birth and breast cancer risk.

Authors:  B MacMahon; P Cole; T M Lin; C R Lowe; A P Mirra; B Ravnihar; E J Salber; V G Valaoras; S Yuasa
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

6.  Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants.

Authors:  M Lundell; A Mattsson; P Karlsson; E Holmberg; A Gustafsson; L E Holm
Journal:  Radiat Res       Date:  1999-05       Impact factor: 2.841

7.  Breast cancer among women given X-ray therapy for acute postpartum mastitis.

Authors:  R E Shore; N Hildreth; E Woodard; P Dvoretsky; L Hempelmann; B Pasternack
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

8.  Breast cancer in women with scoliosis exposed to multiple diagnostic x rays.

Authors:  D A Hoffman; J E Lonstein; M M Morin; W Visscher; B S Harris; J D Boice
Journal:  J Natl Cancer Inst       Date:  1989-09-06       Impact factor: 13.506

9.  Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts.

Authors:  J D Boice; D Preston; F G Davis; R R Monson
Journal:  Radiat Res       Date:  1991-02       Impact factor: 2.841

10.  Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients.

Authors:  F G Davis; J D Boice; Z Hrubec; R R Monson
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

View more
  11 in total

1.  Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.

Authors:  Xiao-Feng He; Wu Wei; Jiao Su; Zi-Xuan Yang; Yi Liu; Ying Zhang; Da-Peng Ding; Wei Wang
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

2.  Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.

Authors:  Bin Kong; Zhi-Dong Lv; Li Chen; Ruo-Wu Shen; Li-Ying Jin; Zhao-Chuan Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Bioavailable serum estradiol may alter radiation risk of postmenopausal breast cancer: a nested case-control study.

Authors:  Eric J Grant; John B Cologne; Gerald B Sharp; Hidetaka Eguchi; Richard G Stevens; Shizue Izumi; Young-Min Kim; Amy Berrington de González; Waka Ohishi; Kei Nakachi
Journal:  Int J Radiat Biol       Date:  2018-01-16       Impact factor: 2.694

4.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

Authors:  Deirdre A Hill; Ethel Gilbert; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars Van't Veer; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle E Curtis; James M Allan; John D Boice; Lois B Travis
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

Review 6.  ATM and genome maintenance: defining its role in breast cancer susceptibility.

Authors:  Kum Kum Khanna; Georgia Chenevix-Trench
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

7.  Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.

Authors:  M Jacob Adams; Ann Dozier; Roy E Shore; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Paul Winters; Susan G Fisher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

Review 8.  Individual response of humans to ionising radiation: governing factors and importance for radiological protection.

Authors:  K E Applegate; W Rühm; A Wojcik; M Bourguignon; A Brenner; K Hamasaki; T Imai; M Imaizumi; T Imaoka; S Kakinuma; T Kamada; N Nishimura; N Okonogi; K Ozasa; C E Rübe; A Sadakane; R Sakata; Y Shimada; K Yoshida; S Bouffler
Journal:  Radiat Environ Biophys       Date:  2020-03-07       Impact factor: 1.925

Review 9.  Radiation and breast cancer: a review of current evidence.

Authors:  Cécile M Ronckers; Christine A Erdmann; Charles E Land
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

10.  The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women.

Authors:  Peijian Ding; Yang Yang; Luyang Cheng; Xuejun Zhang; Limin Cheng; Caizhen Li; Jianhui Cai
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.